These data suggested that the FOXD3 gene might play a tumor suppressor role by activating the EGFR-RAS-Raf-MEK-ERK signaling pathway, thereby providing a novel target for the treatment of colon cancer bone metastasis, which should be explored in future studies. This evidence concerns the gene EGFR and malignant colon neoplasm.